BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Business

  ImmunoGen, Inc. Licenses Anti-Cancer Technology to Amgen (JOBS); ImmunoGen to Get Up to $34 Million in Milestone Payments

  November 20, 2009

   · 

  1 min read
• Xigen S.A., Swiss Developer of Therapeutic Peptides, Raises $20 Million in Series B Funding

  November 20, 2009

   · 

  1 min read
• Drug Development

  Roche’s (JOBS) Actemra Successful in Arthritis Study; Meets Primary Endpoint in Phase III Study

  November 20, 2009

   · 

  1 min read
• Policy

  FDA Panel Rejects Protein Sciences Corporation’s Cell Culture Flu Vaccine, Wants More Safety Data

  November 20, 2009

   · 

  1 min read
• Deals

  Procter & Gamble Repurchasing Shares, Quiet on Potential Deals

  November 20, 2009

   · 

  1 min read
• Policy

  Cell Therapeutics, Inc. Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group

  November 20, 2009

   · 

  2 min read
• FDA

  FDA Approves Intravenous Formulation Of Pfizer Inc.'s (JOBS) Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension

  November 20, 2009

   · 

  5 min read
• Newron Pharmaceuticals Raises CHF7.9m (7.75m USD) In A Private Placement To International Institutional Investors

  November 20, 2009

   · 

  2 min read
• Drug Development

  Pozen, Inc. Announces Start of Enrollment For PA32540 Phase 3 Program

  November 20, 2009

   · 

  1 min read
• FDA

  Boston Scientific Corporation (JOBS) Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

  November 20, 2009

   · 

  5 min read